spark
-
Health & Medicine
Trump’s Investments in Weight-Loss Drug Maker Eli Lilly Spark Ethics Concerns Amid Policy Shifts
President Donald Trump’s public pronouncements on GLP-1 medications, hailed as revolutionary treatments for diabetes and obesity, have taken on new…
Read More » -
Health & Medicine
A Double-Edged Sword: New Hunter Syndrome Drug Offers Hope, But Age Restrictions Spark Urgent Calls for Equitable Access
The recent Food and Drug Administration (FDA) approval of Avlayah (tividenofusp alfa-eknm) for Hunter syndrome marks a significant advancement in…
Read More »
